Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
The Ensign Group
ENSG
$10.6B
| $7.32M | 0.02% |
345,928
-187,289
| -35% | -$3.94M |
|
|
TLN
1202
DELISTED
Talen Energy Corporation
TLN
| $7.31M | 0.02% |
1,173,527
+907,316
| +341% | +$7.48M |
|
1203
Regency Centers
REG
$13.9B
| $7.3M | 0.02% |
107,200
+88,800
| +483% | +$5.91M |
|
|
PFPT
1204
DELISTED
Proofpoint, Inc.
PFPT
| $7.3M | 0.02% |
+112,300
| New | +$7.52M |
|
1205
Build-A-Bear
BBW
$464M
| $7.28M | 0.02% |
594,600
+18,200
| +3% | +$267K |
|
1206
Sarepta Therapeutics
SRPT
$1.94B
| $7.28M | 0.02% |
188,578
-319,160
| -63% | -$10.3M |
|
|
BONA
1207
DELISTED
BONA FILM GROUP LTD SPONSORED ADS
BONA
| $7.27M | 0.02% |
549,500
+311,200
| +131% | +$3.95M |
|
1208
Magnite
MGNI
$3.49B
| $7.27M | 0.02% |
441,900
+8,100
| +2% | +$125K |
|
|
MODN
1209
DELISTED
MODEL N, INC.
MODN
| $7.25M | 0.02% |
650,000
+352,000
| +118% | +$3.75M |
|
1210
Employers Holdings
EIG
$864M
| $7.24M | 0.02% |
265,272
+34,172
| +15% | +$882K |
|
1211
Gerdau
GGB
$9.48B
| $7.23M | 0.02% |
7,595,154
+3,001,698
| +65% | +$3.47M |
|
|
FFNW
1212
DELISTED
First Financial Northwest, Inc
FFNW
| $7.23M | 0.02% |
517,756
+8,156
| +2% | +$107K |
|
|
TSL
1213
DELISTED
Trina Solar Limited
TSL
| $7.22M | 0.02% |
655,500
+174,400
| +36% | +$1.79M |
|
|
RSO
1214
DELISTED
Resource Capital Corp.
RSO
| $7.19M | 0.02% |
563,600
+104,600
| +23% | +$1.3M |
|
1215
Independent Bank
INDB
$4.04B
| $7.19M | 0.02% |
154,589
+34,381
| +29% | +$1.65M |
|
1216
CME Group
CME
$94.3B
| $7.19M | 0.02% |
104,995
+74,995
| +250% | +$7.06M |
|
1217
Goodyear
GT
$1.74B
| $7.18M | 0.02% |
+219,700
| New | +$7.2M |
|
|
AIRM
1218
DELISTED
Air Methods Corp
AIRM
| $7.16M | 0.02% |
170,800
-33,400
| -16% | -$1.36M |
|
1219
Ambarella
AMBA
$3.66B
| $7.16M | 0.02% |
128,450
-83,150
| -39% | -$4.69M |
|
|
PTLA
1220
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.16M | 0.02% |
139,100
+115,300
| +484% | +$5.59M |
|
|
AHRT
1221
AH Realty Trust
AHRT
$501M
| $7.15M | 0.02% |
682,257
+87,963
| +15% | +$938K |
|
1222
Liberty Media Series A
FWONA
$23.7B
| $7.15M | 0.02% |
270,839
+35,695
| +15% | +$951K |
|
1223
Arrow Financial
AROW
$725M
| $7.14M | 0.02% |
333,143
+38,510
| +13% | +$846K |
|
|
SJI
1224
DELISTED
South Jersey Industries, Inc.
SJI
| $7.14M | 0.02% |
303,500
-43,800
| -13% | -$1.07M |
|
|
MN
1225
DELISTED
MANNING & NAPIER, INC.
MN
| $7.13M | 0.02% |
839,900
+86,400
| +11% | +$732K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.